A Study to Compare the Relative Bioavailability of Brigatinib When Swallowed as a Solution Versus When Swallowed as a Tablet in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The main aim of this study is to compare the amount of brigatinib in the blood of healthy adults after they have swallowed one dose either as a solution or as a tablet.
Epistemonikos ID: 2b7f835c8a5b9f78fcfadb587ab2e533ca62d45e
First added on: May 15, 2024